- Ketamine Is Now An FDA-Approved Depression Treatment, But Who Will Be Able To Get It? Gizmodo Australia
- A ketamine-like nasal spray emerges as the first new anti-depressant in 30 years Happy
- Ketamine-Like Depression Drug Isn’t a Surefire Hit Bloomberg
- A Ketamine-Based Nasal Spray For Depression Has Just Been Approved by The FDA ScienceAlert
- J&J prices ketamine-like depression treatment at $590-$885 for two doses Reuters
- View full coverage on Google News
Ketamine Is Now An FDA-Approved Depression Treatment, But Who Will Be Able To Get It? – Gizmodo Australia
ByGoogle News
Mar 7, 2019